Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-23-109942

Interim CEO & General Counsel gave up 8,851 shares (to pay taxes)

  • Interim CEO & General Counsel acquired 20,835 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Vogt Frederick G · Interim CEO & General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-10-16 Exercise or conversion : show line 1 in the form +20,835 93,685 D
2023-10-16 Shares withheld for taxes : show line 2 in the form −8,851 $3.57 $31,598 84,834 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-10-16 Exercise or conversion : show line 3 in the form Restricted Stock Units −20,835 104,172 D
Loading xslF345X05/tm2328751-3_4seq1.xml…